TORRENT PHARMA DERMA PRODUCTS HOW TO
TORRENT PHARMA DERMA PRODUCTS TORRENT

Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger.

TORRENT PHARMA DERMA PRODUCTS TORRENT

With annual revenues of Rs 4,700 crore, Torrent Pharma has plants in Indrad, Baddi, Sikkim and Dahej and has recently acquired a plant in Pithampur, Madhya Pradesh to produce derma products.Д«usiness Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Torrent has launched new generation Hepatitis C antiviral Sofosbuvir under the brand name Sofocruz, a combination of Sofosbuvir and Ledipasvir called Sofocruz LP and Daclatasvir (brand name Dclacruz). Ruchir Modi, executive director, marketing of Torrent Pharma said that the company now covers most of the specialities and plans to enter the urology and opthalmology segments in the near future.Д«esides promoting biosimilar Adalimumab Adfrar IB to gastroenterologists, the super speciality task force would also cater to the needs in hepatology. According to the terms of the agreement, Reliance Life Sciences will manufacture these products at its facility in Navi Mumbai and supply to Torrent Pharma for a period of 10 years, after obtaining all necessary regulatory approvals.

While Rituximab and Cetuximab cater to the oncology segment and are used in the treatment of various cancers such as leukaemia, lymphoma, colorectal, head and neck, Adalimumab is the therapy for the treatment of auto-immune disorders such as rheumatoid arthritis, psoriasis and inflammatory bowel disease (IBD). It had entered into an exclusive licensing agreement with Reliance Life Sciences for marketing three biosimilars in India - Rituximab, Adalimumab and Cetuximab. Torrent is already marketing the biosimilar of Rituximab under the brand name Toritz in oncology segment while a super speciality division for nephrology launched in 2014 is marketing the biosimilar of Darbepoetin alpha (Darbatitor). Torrent's Adfrar will be available as pre-filled syringe of 40mg, and the company plans to promote its drug to rheumatologists, gastroenterologists and dermatologists pan India.ДЇor this, three separate super speciality task force have been introduced, and around 100 trained professionals are employed in these greenfield divisions.

Torrent Pharma Derma Products